| Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study J García-Abellán, S Padilla, M Fernández-González, JA García, V Agulló, ... Journal of clinical immunology 41 (7), 1490-1501, 2021 | 122 | 2021 |
| Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study V Agulló, M Fernández-González, VO de la Tabla, N Gonzalo-Jiménez, ... The Journal of Infection 82 (5), 186, 2021 | 80 | 2021 |
| Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study M Masiá, M Fernández-González, S Padilla, P Ortega, JA García, V Agulló, ... EBioMedicine 60, 2020 | 80 | 2020 |
| SARS-CoV-2 seroconversion and viral clearance in patients hospitalized with COVID-19: viral load predicts antibody response M Masiá, G Telenti, M Fernández, JA García, V Agulló, S Padilla, ... Open forum infectious diseases 8 (2), ofab005, 2021 | 72 | 2021 |
| Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study S Serrano-Villar, J Martínez-Sanz, R Ron, A Talavera-Rodríguez, ... The lancet HIV 7 (8), e565-e573, 2020 | 53 | 2020 |
| Preemptive interleukin-6 blockade in patients with COVID-19 L Guillén, S Padilla, M Fernández, V Agulló, JA García, G Telenti, ... Scientific Reports 10 (1), 16826, 2020 | 50 | 2020 |
| Nasopharyngeal Panbio COVID-19 antigen performed at point-of-care has a high sensitivity in symptomatic and asymptomatic patients with higher risk for transmission and older age M Masiá, M Fernández-González, M Sánchez, M Carvajal, JA García, ... Open Forum Infectious Diseases 8 (3), ofab059, 2021 | 49 | 2021 |
| Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study M Masiá, M Fernández-González, G Telenti, V Agulló, JA García, ... Journal of autoimmunity 123, 102703, 2021 | 42 | 2021 |
| Immunologic phenotype of patients with long-COVID syndrome of 1-year duration J García-Abellán, M Fernández, S Padilla, JA García, V Agulló, V Lozano, ... Frontiers in Immunology 13, 920627, 2022 | 34 | 2022 |
| Performance of saliva specimens for the molecular detection of SARS-CoV-2 in the community setting: does sample collection method matter? M Fernández-González, V Agulló, A de La Rica, A Infante, M Carvajal, ... Journal of clinical microbiology 59 (4), 10.1128/jcm. 03033-20, 2021 | 34 | 2021 |
| Short-term increase in risk of overweight and concomitant systolic blood pressure elevation in treatment-naïve persons starting INSTI-based antiretroviral therapy R Galdamez, JA García, M Fernández, C Robledano, V Agulló, ... Open forum infectious diseases 6 (12), ofz491, 2019 | 21 | 2019 |
| Clinical performance of a standardized SARS-CoV-2 interferon-γ release assay for simple detection of T-cell responses after infection or vaccination M Fernández-González, V Agulló, S Padilla, JA García, J García-Abellán, ... Clin Infect Dis 10, ciab1021, 2021 | 17 | 2021 |
| Clinical performance of a standardized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interferon-γ release assay for simple detection of T-cell responses after … M Fernández-González, V Agulló, S Padilla, JA García, J García-Abellán, ... Clinical Infectious Diseases 75 (1), e338-e346, 2022 | 15 | 2022 |
| Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade M Masiá, M Fernández-González, JA García, S Padilla, J García-Abellán, ... EBioMedicine 82, 2022 | 13 | 2022 |
| Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection M Masiá, S Padilla, G Estañ, J Portu, A Silva, A Rivero, ... Trials 22, 1-11, 2021 | 12 | 2021 |
| Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID J García-Abellán, S Padilla, M Fernández-González, JA García, V Agulló, ... medRxiv, 2021.03. 08.21253124, 2021 | 10 | 2021 |
| Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events J Martínez-Sanz, J Díaz-Álvarez, M Rosas, R Ron, JA Iribarren, E Bernal, ... EBioMedicine 95, 2023 | 9 | 2023 |
| Infection With Chlamydia trachomatis Increases the Risk of High-grade Anal Intraepithelial Neoplasia in People Living With Human Immunodeficiency Virus M Masiá, M Fernández-González, JA García, S Padilla, E García-Payá, ... Clinical Infectious Diseases 70 (10), 2161-2167, 2020 | 9 | 2020 |
| Rectal and seminal HIV-1 RNA decay towards virological suppression in infected MSM initiating dolutegravir/abacavir/lamivudine M Fernández-González, JA García, S Padilla, J García-Abellán, V Agulló, ... Journal of Antimicrobial Chemotherapy 75 (3), 668-674, 2020 | 9 | 2020 |
| T-cell immunity against SARS-CoV-2 measured by an interferon-γ release assay is strongly associated with patient outcomes in vaccinated persons hospitalized with Delta or … M Fernández-González, V Agulló, JA García, S Padilla, J García-Abellán, ... The Journal of Infectious Diseases, jiad260-jiad260, 2023 | 3 | 2023 |
